• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acadia Healthcare upgraded by Deutsche Bank with a new price target

    4/25/24 6:31:01 AM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email
    Deutsche Bank upgraded Acadia Healthcare from Sell to Hold and set a new price target of $70.00
    Get the next $ACHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    9/10/2025$25.00Buy → Neutral
    BofA Securities
    8/14/2025$26.00Strong Buy → Outperform
    Raymond James
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    4/25/2024$70.00Sell → Hold
    Deutsche Bank
    3/6/2024$100.00Overweight
    Barclays
    More analyst ratings

    $ACHC
    SEC Filings

    View All

    Acadia Healthcare Company Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    9/29/25 7:05:56 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.

    SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    8/12/25 10:34:26 AM ET
    $ACHC
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Acadia Healthcare Company Inc.

    10-Q - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    8/5/25 4:45:57 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Khrom Capital Sends Letter to Board of Directors of Acadia Healthcare

    Acadia Healthcare Has Suffered Consistent Underperformance Under Current Leadership Believes Acadia Healthcare Should Launch a Formal Review of Strategic Alternatives to Maximize Value for Shareholders Khrom Capital Management LLC ("Khrom Capital"), which together with its investment funds and affiliates, owns 5.5% of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") and is one of the Company's largest shareholders, today sent a letter to the Company's Board of Directors reiterating its belief that the Company should pursue a formal review of strategic alternatives, including a sale, in order to maximize value for its shareholders. The letter can be downloaded

    10/1/25 4:59:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Issues Statement Highlighting Commitment to Value Creation

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today issued the following statement: Our Board of Directors and management team are steadfast in our commitment to enhancing long-term shareholder value. We regularly communicate with our shareholders regarding our value creation plan and welcome constructive input as we move forward. At Acadia, our mission is to create a world-class organization that sets the standard of excellence in the treatment of behavioral health and substance use disorders, and we are executing a focused strategy to position Acadia for the future. Our actions are centered on disciplined growth to expand access to high-quality behavioral healthcare, strengthening cli

    9/24/25 11:49:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Engine Capital Sends Letter to Acadia Healthcare's Board of Directors Regarding the Urgent Need for Strategy and Governance Changes

    Highlights That the Company Has Delivered Negative Returns and Underperformed Other Healthcare Facility Operators Over All Relevant Periods – Causing it to Trade at a Deep Discount to its Intrinsic Value Believes Acadia's Underperformance Stems from Poor Execution, a Flawed Reorganization Under CEO Christopher Hunter, Ballooning Costs, Poor Capital Allocation, and a Lack of Board Oversight Urges the Company to Immediately Halt Growth Capital Projects, Prioritize Operational and Cost Structure Improvements, Explore Potential Asset Sales, and Repurchase Undervalued Shares Makes Clear the Board Needs to Be Refreshed with New Directors Who Bring Behavioral Health Operating Experience and

    9/24/25 8:30:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Acadia Healthcare downgraded by BofA Securities with a new price target

    BofA Securities downgraded Acadia Healthcare from Buy to Neutral and set a new price target of $25.00

    9/10/25 7:57:54 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by Raymond James with a new price target

    Raymond James downgraded Acadia Healthcare from Strong Buy to Outperform and set a new price target of $26.00

    8/14/25 8:17:37 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously

    2/28/25 7:39:54 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Khan Nasser covered exercise/tax liability with 973 shares, decreasing direct ownership by 2% to 55,023 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    10/1/25 5:01:03 PM ET
    $ACHC
    Medical Specialities
    Health Care

    New insider Sides Timothy August claimed ownership of 30,661 shares (SEC Form 3)

    3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    8/25/25 5:01:03 PM ET
    $ACHC
    Medical Specialities
    Health Care

    EVP, GC and Secretary Farley Brian covered exercise/tax liability with 1,095 shares, decreasing direct ownership by 2% to 71,080 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    7/29/25 5:01:04 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R

    4/11/24 2:16:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i

    4/4/24 9:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Financials

    Live finance-specific insights

    View All

    Acadia Healthcare Reports Second Quarter 2025 Results

    Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per

    8/5/25 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for Second Quarter 2025 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Wednesday, August 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2025, Acadia operated a network of 270 behavioral healthcare facilities

    7/18/25 11:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Reports First Quarter 2025 Results

    Affirms Full Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenue totaled $770.5 million, compared with $768.1 million for the first quarter of 2024 Same facility revenue increased 2.1% compared with the first quarter of 2024, including an increase in patient days of 2.2% Same facility revenue and patient day growth both included an unfavorable year-over-year impact from the leap year of approximately 1.1% Net income attributable to Acadia totaled $8.4 million, or $0.09 per diluted share Adjusted income attributable to Acadia

    5/12/25 4:07:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/14/24 1:28:32 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/12/24 9:50:14 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/8/24 10:52:39 AM ET
    $ACHC
    Medical Specialities
    Health Care